Total Payments
$51,077
2024 Payments
$7,365
Companies
9
Transactions
72
Medicare Patients
2,070
Medicare Billing
$268,552
Payment Breakdown by Category
Other$45,604 (89.3%)
Food & Beverage$2,772 (5.4%)
Consulting$2,220 (4.3%)
Travel$456.47 (0.9%)
Education$24.12 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,604 | 28 | 89.3% |
| Food and Beverage | $2,772 | 37 | 5.4% |
| Consulting Fee | $2,220 | 3 | 4.3% |
| Travel and Lodging | $456.47 | 3 | 0.9% |
| Education | $24.12 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $48,626 | 47 | $0 (2024) |
| NEUROPACE, INC. | $982.79 | 7 | $0 (2017) |
| SK Life Science, Inc. | $483.31 | 4 | $0 (2024) |
| NATUS MEDICAL INCORPORATED | $287.65 | 3 | $0 (2019) |
| EISAI INC. | $249.06 | 3 | $0 (2019) |
| LivaNova USA, Inc. | $230.79 | 4 | $0 (2018) |
| Ceribell, Inc. | $118.36 | 1 | $0 (2018) |
| Neurelis, Inc. | $68.26 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $29.92 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,365 | 6 | UCB, Inc. ($7,246) |
| 2023 | $3,274 | 5 | UCB, Inc. ($3,206) |
| 2022 | $10,454 | 10 | UCB, Inc. ($10,206) |
| 2021 | $5,886 | 9 | UCB, Inc. ($5,770) |
| 2020 | $1,515 | 3 | UCB, Inc. ($1,500) |
| 2019 | $6,077 | 7 | UCB, Inc. ($5,775) |
| 2018 | $6,377 | 10 | UCB, Inc. ($5,864) |
| 2017 | $10,128 | 22 | UCB, Inc. ($9,060) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $199.67 | General |
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $119.12 | General |
| Category: Neurology | ||||||
| 10/24/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Neurology | ||||||
| 10/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $123.35 | General |
| Category: Neurology | ||||||
| 05/06/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Neurology | ||||||
| 04/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $123.35 | General |
| Category: Neurology | ||||||
| 12/19/2023 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Neurology | ||||||
| 11/20/2023 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,160.00 | General |
| Category: Neurology | ||||||
| 11/20/2023 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $26.72 | General |
| Category: Neurology | ||||||
| 11/13/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $68.26 | General |
| Category: EPILEPSY | ||||||
| 11/08/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $118.85 | General |
| Category: Neurology | ||||||
| 12/19/2022 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,160.00 | General |
| Category: Neurology | ||||||
| 12/09/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: Neurology | ||||||
| 08/29/2022 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,160.00 | General |
| Category: Neurology | ||||||
| 08/18/2022 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $72.83 | General |
| Category: Neurology | ||||||
| 07/06/2022 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Neurology | ||||||
| 04/26/2022 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,160.00 | General |
| Category: Neurology | ||||||
| 03/28/2022 | UCB, Inc. | Briviact (Drug) | Consulting Fee | Cash or cash equivalent | $720.00 | General |
| Category: Neurology | ||||||
| 02/15/2022 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 01/20/2022 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.23 | General |
| Category: Neurology | ||||||
| 01/20/2022 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $124.23 | General |
| Category: Neurology | ||||||
| 11/29/2021 | UCB, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| 11/22/2021 | UCB, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| 11/15/2021 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Neurology | ||||||
| 11/05/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 567 | 735 | $218,698 | $66,286 |
| 2022 | 9 | 500 | 643 | $188,276 | $56,798 |
| 2021 | 9 | 500 | 656 | $193,678 | $61,328 |
| 2020 | 9 | 503 | 819 | $263,699 | $84,140 |
Total Patients
2,070
Total Services
2,853
Medicare Billing
$268,552
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 48 | 163 | $86,390 | $25,355 | 29.3% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 214 | 219 | $50,370 | $13,756 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 90 | $18,630 | $7,092 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 55 | $15,895 | $6,648 | 41.8% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 30 | 39 | $13,338 | $3,952 | 29.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $7,650 | $2,880 | 37.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 60 | 61 | $8,845 | $2,551 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 45 | $7,875 | $2,044 | 26.0% |
| 95717 | Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | Facility | 2023 | 20 | 24 | $6,240 | $1,760 | 28.2% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 13 | 21 | $3,465 | $249.39 | 7.2% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 47 | 147 | $77,910 | $23,188 | 29.8% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2022 | 173 | 176 | $40,480 | $10,929 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 74 | $15,318 | $6,066 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 45 | $13,005 | $4,969 | 38.2% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 35 | 44 | $15,048 | $4,182 | 27.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 85 | 85 | $12,325 | $3,534 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 39 | $6,825 | $2,200 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,900 | $1,469 | 37.7% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 12 | 21 | $3,465 | $260.79 | 7.5% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 31 | 157 | $83,210 | $25,806 | 31.0% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Facility | 2021 | 177 | 179 | $41,170 | $12,017 | 29.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 53 | $15,020 | $6,378 | 42.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 79 | $15,947 | $5,412 | 33.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 90 | 90 | $13,050 | $3,916 | 30.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $7,650 | $3,151 | 41.2% |
About Dr. John Croom, MD
Dr. John Croom, MD is a Epilepsy healthcare provider based in Merriam, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952352908.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Croom, MD has received a total of $51,077 in payments from pharmaceutical and medical device companies, with $7,365 received in 2024. These payments were reported across 72 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,604).
As a Medicare-enrolled provider, Croom has provided services to 2,070 Medicare beneficiaries, totaling 2,853 services with total Medicare billing of $268,552. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology, Epilepsy
- Location Merriam, KS
- Active Since 05/15/2006
- Last Updated 10/28/2025
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1952352908
Products in Payments
- Briviact (Drug) $37,065
- Nayzilam (Drug) $9,862
- RNS System (Device) $982.79
- XCOPRI (Drug) $483.31
- Fycompa (Drug) $249.06
- VNS Therapy (Device) $230.79
- VALTOCO (Drug) $68.26
- APTIOM (Drug) $29.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.